Carl Bjartmar

3.8k total citations
30 papers, 2.9k citations indexed

About

Carl Bjartmar is a scholar working on Developmental Neuroscience, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Carl Bjartmar has authored 30 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Developmental Neuroscience, 9 papers in Neurology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Carl Bjartmar's work include Neurogenesis and neuroplasticity mechanisms (17 papers), Peripheral Neuropathies and Disorders (9 papers) and Multiple Sclerosis Research Studies (8 papers). Carl Bjartmar is often cited by papers focused on Neurogenesis and neuroplasticity mechanisms (17 papers), Peripheral Neuropathies and Disorders (9 papers) and Multiple Sclerosis Research Studies (8 papers). Carl Bjartmar collaborates with scholars based in United States, Sweden and United Kingdom. Carl Bjartmar's co-authors include Bruce D. Trapp, Jerome R. Wujek, Grahame J. Kidd, Richard A. Rudick, C. Hildebrand, Håkan Persson, S. Remahl, Xinghua Yin, R. Philip Kinkel and Nobuo Terada and has published in prestigious journals such as Neurology, Annals of Neurology and Brain Research.

In The Last Decade

Carl Bjartmar

30 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Bjartmar United States 18 1.4k 776 682 585 584 30 2.9k
Alastair Wilkins United Kingdom 30 620 0.4× 744 1.0× 979 1.4× 725 1.2× 562 1.0× 71 2.8k
Maria Teresa Giordana Italy 28 706 0.5× 266 0.3× 855 1.3× 366 0.6× 483 0.8× 65 2.6k
Josa M. Frischer Austria 22 2.3k 1.6× 608 0.8× 1.1k 1.6× 304 0.5× 1.2k 2.0× 58 4.2k
Xinghua Yin United States 23 749 0.5× 880 1.1× 1.3k 1.9× 1.2k 2.0× 1.2k 2.0× 31 3.5k
Betty Soliven United States 35 589 0.4× 483 0.6× 1.6k 2.3× 936 1.6× 585 1.0× 86 3.9k
Matthew Craner United Kingdom 22 1.3k 0.9× 333 0.4× 1.4k 2.1× 838 1.4× 547 0.9× 31 3.8k
Jerome R. Wujek United States 15 684 0.5× 444 0.6× 505 0.7× 603 1.0× 679 1.2× 17 2.2k
Shanu F. Roemer United States 13 1.8k 1.3× 235 0.3× 576 0.8× 295 0.5× 654 1.1× 22 2.8k
Simon Hametner Austria 27 2.2k 1.6× 400 0.5× 1.0k 1.5× 218 0.4× 1.2k 2.0× 66 4.0k
James Garbern United States 39 478 0.3× 636 0.8× 2.2k 3.3× 1.4k 2.4× 755 1.3× 78 4.2k

Countries citing papers authored by Carl Bjartmar

Since Specialization
Citations

This map shows the geographic impact of Carl Bjartmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Bjartmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Bjartmar more than expected).

Fields of papers citing papers by Carl Bjartmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Bjartmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Bjartmar. The network helps show where Carl Bjartmar may publish in the future.

Co-authorship network of co-authors of Carl Bjartmar

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Bjartmar. A scholar is included among the top collaborators of Carl Bjartmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Bjartmar. Carl Bjartmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Członkowska, Anna, Tomasz Litwin, Karolina Dzieżyc, et al.. (2018). Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson’s Disease Rating Scale. BMC Neurology. 18(1). 34–34. 43 indexed citations
2.
Thurberg, Beth L., Pierre G. Carlier, John T. Kissel, et al.. (2015). A Phase 4 Prospective Study in Patients with Adult Pompe Disease Treated with Alglucosidase Alfa. Journal of Neuromuscular Diseases. 2(s1). S72–S73. 1 indexed citations
3.
Case, Laura E., Carl Bjartmar, Claire Morgan, et al.. (2014). Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease. Neuromuscular Disorders. 25(4). 321–332. 44 indexed citations
4.
Terada, Nobuo, Grahame J. Kidd, Michael Kinter, et al.. (2005). ?IV tubulin is selectively expressed by oligodendrocytes in the central nervous system. Glia. 50(3). 212–222. 28 indexed citations
5.
Bjartmar, Carl & Bruce D. Trapp. (2003). Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotoxicity Research. 5(1-2). 157–164. 110 indexed citations
6.
Bjartmar, Carl, Jerome R. Wujek, & Bruce D. Trapp. (2003). Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. Journal of the Neurological Sciences. 206(2). 165–171. 443 indexed citations
7.
Terada, Nobuo, Michael Kinter, Peter Brophy, et al.. (2002). The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to β1 integrin, CD81, and Tspan‐2. Glia. 40(3). 350–359. 60 indexed citations
8.
Bjartmar, Carl & Robert J. Fox. (2002). Pathological mehanisms and disease progression of multiplesclerosis: Therapeutic implications. Drugs of today. 38(1). 17–17. 1 indexed citations
9.
Bjartmar, Carl & Bruce D. Trapp. (2001). Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Current Opinion in Neurology. 14(3). 271–278. 388 indexed citations
11.
Bjartmar, Carl, et al.. (2001). Postmortem Degradation of N-Acetyl Aspartate and N-Acetyl Aspartylglutamate: An HPLC Analysis of Different Rat CNS Regions. Neurochemical Research. 26(6). 695–702. 20 indexed citations
12.
Bjartmar, Carl, et al.. (2000). Developing chicken oligodendrocytes express the type IV oligodendrocyte marker T4-O in situ, but not in vitro. Neuroscience Letters. 284(1-2). 21–24. 4 indexed citations
13.
Bjartmar, Carl, et al.. (2000). Myelination of prospective large fibres in chicken ventral funiculus. Journal of Neurocytology. 29(10). 755–764. 12 indexed citations
14.
Bjartmar, Carl, et al.. (1999). Molecular heterogeneity of oligodendrocytes in chicken white matter.. PubMed. 27(1). 15–21. 18 indexed citations
15.
Bjartmar, Carl, et al.. (1999). Molecular heterogeneity of oligodendrocytes in chicken white matter. Glia. 27(1). 15–21. 2 indexed citations
16.
Bjartmar, Carl. (1998). Morphological heterogeneity of cultured spinal and cerebral rat oligodendrocytes. Neuroscience Letters. 247(2-3). 91–94. 11 indexed citations
17.
Bjartmar, Carl. (1996). Oligodendroglial sheath lengths in developing rat ventral funiculus and corpus callosum. Neuroscience Letters. 216(2). 85–88. 8 indexed citations
18.
Hildebrand, C., et al.. (1996). Sheath lengths of large motor axons in the ventral root L5 of neonatal and adult rats. Neuroscience Letters. 202(3). 173–176. 6 indexed citations
19.
Bjartmar, Carl, Björn Karlsson, & C. Hildebrand. (1994). Cellular and extracellular components at nodes of Ranvier in rat white matter. Brain Research. 667(1). 111–114. 12 indexed citations
20.
Bjartmar, Carl, et al.. (1994). Morphological heterogeneity of rat oligodendrocytes: Oligodendrocytes: Electron microscopic studies on serial sections. Glia. 11(3). 235–244. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026